Posaconazole Tablet, Delayed Release
Product Images NDC 60687-523

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 60687-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20ud Carton

20ud Carton
Posaconazole 100 mg delayed-release tablets label showing packaging for 20 tablets (2 x 10) by American Health Packaging. The label includes dosage form, strength, NDC 60687-523-94, storage instructions, and safety information emphasizing non-interchangeability with oral suspension.*
FDA Label Image

30ud Carton

30ud Carton
Posaconazole 100 mg delayed-release tablets label shows the product name, dosage form, strength, and the quantity of 30 tablets (3 x 10). It includes storage instructions, a warning that oral suspension and delayed-release tablets are not interchangeable, dosage content, and distributor information from American Health Packaging, Columbus, Ohio. The label also displays the NDC number 60687-523-21 and a barcode.*
FDA Label Image

Ahp52321

Ahp52321
Posaconazole 100 mg delayed-release oral tablet shown front and back. The tablet is oblong, pale yellow, with the imprint "100" on one side. A millimeter ruler scale indicates the tablet size is approximately 15 mm long.*
FDA Label Image

Blister

Blister
Sheet of multiple Posaconazole 100 mg delayed-release tablet labels from American Health Packaging. Each label includes the product name, strength, dosage form, barcode, expiration date, lot number, and manufacturer information for NDC 60687-523.*
FDA Label Image

Structure

Structure
Chemical structure of posaconazole, depicting its molecular framework including fluorinated aromatic rings, triazole groups, and hydroxylated side chains as typically represented in pharmaceutical structural diagrams.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.